Guide 07 — AI Governance in Healthcare

A practical map of accountability from idea to production.

Seven governance domains, an EU reality check for Sep 2026, and who needs to be in the room.

A4 sheet — scroll sideways or pinch to zoom

Visual Guide 07 · Governance / Foundation / Practitioner

AI Governance in Healthcare

A practical map of accountability from idea to production.

Healthcare AI Learning

1Intended purpose & ownership

What problem and use case?
Who owns clinical, business and product decisions?
Who can stop use?

2Data & privacy

Lawful basis and appropriate governance
Minimisation, access, retention
Data quality and provenance
Sensitive-data controls; GDPR where personal data is processed

3Model, evidence & evaluation

Intended population and performance
Subgroup analysis and limitations
Validation and documentation
Change control

4Security & technical controls

Identity and access, secrets
Tool permissions
Vendor and supply-chain risk
Logging, resilience, cybersecurity

5Workflow & human oversight

Who reviews and who acts
Escalation and override
Accountability and training
Usability and human factors

6Regulatory classification — where applicable

EU AI Act: obligations depend on risk, role and use case; phased over time
Do not assume all healthcare AI is high-risk
MDR / IVDR: software may be regulated when intended purpose and classification bring it in scope
Local, national and organisational requirements may also apply

7Deployment, monitoring & incidents

Post-deployment monitoring
Quality and safety signals, complaints
Drift and change
Incident response, revalidation, retirement

EU reality check — Sep 2026

The EU AI Act entered into force in 2024 and is in application with phased obligations.
Certain transparency obligations apply from 2 August 2026; checked against the official text in September 2026.
High-risk transition dates differ by category and product route. Under Regulation (EU) 2026/1744, Chapter III Sections 1–3 apply from 2 December 2027 for Article 6(2) / Annex III high-risk systems, and from 2 August 2028 for Article 6(1) / Annex I product-route high-risk systems.
These two dates concern those high-risk obligations only and do not generalise to every AI Act obligation; the guide was checked in September 2026 — verify the current official text before relying on a date.
Classification depends on role, intended use and system context.

Educational overview only, not legal advice. Verify current classification, obligations and timelines for your own use case.

Who needs to be in the room?

Clinical ownerProduct / operationsData & privacySecurityQuality / regulatoryTechnical teamEnd users

Governance is continuous, not a one-time approval gate.

Related learning

AI in HealthcareOpen

Agentic AI in HealthcareOpen

Guides summarise the same primary sources cited in the related courses — official EU legal texts, standards bodies and peer-reviewed literature. Educational summaries only, not legal or clinical advice; regulatory dates were checked between 25 August and 10 September 2026.

Updated Sep 2026